TP53 and pancreatic ductal adenocarcinoma: TP53 stands out as the most commonly mutated tumor suppressor gene in pancreatic ductal adenocarcinoma (PDAC), and its functional changes have been linked to various oncogenic outcomes, encompassing heightened genomic instability [33], cellular metabolism reprogramming [34], and augmented metastatic propensity [35].